Mulmit

Ensysce Biosciences, Inc.Ensysce Biosciences, Inc.

ENSC Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-315,066,650-10,240,946-3.98
2024-12-315,210,031-6,730,134-11.45
2023-12-312,230,520-10,718,187-70.4
2022-12-312,523,383-24,222,095-139.42
2021-12-313,531,199-19,870,431-1.48

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-07GOWER BOB G400,000
2026-04-23GOWER BOB G508,614
2026-04-23GOWER BOB G254,307
2023-03-02GOWER BOB G90,287
2023-03-01GOWER BOB G270,000
2023-02-28GOWER BOB G109,300
2022-12-09GOWER BOB G357,143
2022-12-09GOWER BOB G714,286
2022-06-23Chang William H15,000
2022-06-23Martin Steven Robert15,000
2022-06-23Rauch Lee M.15,000
2022-06-23GOWER BOB G15,000

8-K events

FiledItems
2026-08-25Other events
2026-08-24Other events
2026-08-13Results of operations · Financial statements and exhibits
2026-08-06Financial statements and exhibits
2026-08-06Entry into a material agreement · Completed acquisition or disposition of assets · Unregistered sales of equity securities · Material modification to rights of security holders · Officer or director change · Amendments to charter or bylaws · Regulation FD disclosure · Financial statements and exhibits
2026-07-15Officer or director change · Financial statements and exhibits
2026-05-22Delisting or listing-standard notice
2026-05-15Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.